Phase
Condition
Asthma
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Can communicate,
To have an increase of %12 or 200 ml in FEV1 value after inhaler bronchodilator atbreathing function test,
To have chronic asthma diagnose with 6 months approved by doctors and receivingtreatment,
Asthma controls are not under control or partly under control in relation to GINA (Global Initiative for Asthma) values,
Taking beta2-agonist and/or ICS twice a week or more to control asthma symptoms,
There is not any chance in inhaler bronchodilator drug potions during the last fourweeks,
Can use a smart phone.
Exclusion
Exclusion Criteria:
To have lung diseases such as COPD,
To have tuberculosis and respiratory infection,
To have diabetes and coronary artery disease,
Smokers
Pregnant or nursing mother,
Doing regular exercise,
Benefitng from other complementary and integrative health applications duringtreatments
Study Design
Connect with a study center
Nevşehir Haci Bektaş Veli Üniversitesi
Nevşehir, Nerkez 50000
TurkeySite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.